Azathioprine (Imuran)

Subscribe to Selected New Research on Azathioprine

3492 relevant articles (424 outcomes, 370 trials/studies) found for this Drug

Description: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)

Also Known As:

Imuran; Azathioprine Sodium Salt; Azathioprine Sulfate; Azothioprine; Immuran; Imurel; 1H-Purine, 6-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-

Relationship Network

Drug Context: Research Results

Experts

1.	Sandborn, William J: 5 articles (10/2005 - 01/2002)
2.	Ghosh, S: 5 articles (08/2003 - 05/2000)
3.	Lémann, Marc: 4 articles (09/2008 - 01/2002)
4.	Reinisch, W: 4 articles (10/2007 - 03/2001)
5.	Herfarth, Hans: 4 articles (07/2007 - 05/2002)
6.	Bonaz, B: 4 articles (04/2005 - 06/2000)
7.	Campbell, S: 4 articles (08/2003 - 09/2001)
8.	Gisbert, J P: 3 articles (09/2008 - 06/2002)
9.	Nagy, Ferenc: 3 articles (07/2008 - 02/2006)
10.	Domènech, Eugeni: 3 articles (05/2008 - 01/2005)

Related Diseases

1.	Crohn Disease (Crohn's Disease) 04/01/2007 - "CONCLUSIONS: Most patients with Crohn's disease in longstanding remission had low self-reported adherence to azathioprine. " 01/01/2009 - "Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse." 01/17/2000 - "Azathioprine/6MP (AZA/6MP) is effective in long-term treatment (> 3 months) of Crohn's disease and superior to other established medical treatments. " 04/01/1997 - "Medical treatment (corticosteriod therapy, with or without azathioprine) was usually effective initially for treatment of symptomatic colonic Crohn's disease, but sustained remission was rare. " 06/01/2005 - "CONCLUSIONS: This study shows that azathioprine withdrawal is not equivalent to continued therapy with azathioprine for maintenance of remission in patients with Crohn's disease who have been in remission on azathioprine for > or = 3.5 years. " Order ALL the reference details at left...
2.	Ulcerative Colitis 01/01/2002 - "The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis." 07/04/1992 - "CONCLUSIONS--Azathioprine maintenance treatment in ulcerative colitis is beneficial for at least two years if patients have achieved remission while taking the drug. " 05/22/2004 - "OBJECTIVE: To know whether the therapeutic protocol applied in the case of severe acute ulcerative colitis (UC) associating ciclosporine and azathioprine was also effective in the case of moderate chronic active ulcerative colitis (UC). " 10/01/2002 - "CONCLUSIONS: Azathioprine is effective in patients with steroid-dependent or steroid-resistant ulcerative colitis. " 01/01/2003 - "Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis." Order ALL the reference details at left...
3.	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/01/2003 - "Azathioprine (AZA) is an effective treatment for inflammatory bowel disease. " 09/01/2001 - "BACKGROUND: Azathioprine is an effective treatment for maintaining remission in inflammatory bowel disease (IBD). " 02/01/2008 - "Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications." 12/07/2005 - "The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease." 04/01/2002 - "The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review." Order ALL the reference details at left...
4.	Autoimmune Hepatitis 10/01/2007 - "Re: Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis." 09/01/2006 - "Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis." 02/01/2006 - "In > 80% of patients with autoimmune hepatitis, steroid therapy alone or in combination with azathioprine results in disease remission. " 09/01/2000 - "BACKGROUND/AIM: Azathioprine is standard therapy for maintenance of remission in patients with autoimmune hepatitis. " 01/01/1996 - "[Azathioprine maintains remission in autoimmune hepatitis]" Order ALL the reference details at left...
5.	Vasculitis (Vasculitides) 09/01/2001 - "Azathioprine may have induced the remission of vasculitis in one case." 11/01/1973 - "Proceedings: Controlled trial of azathioprine in rheumatoid vasculitis." 07/01/1996 - "We review the literature concerning adverse reactions to azathioprine and the problems of making the diagnosis as well as highlighting azathioprine as a novel cause of leucocytoclastic vasculitis." 07/01/1996 - "He developed histologically proven cutaneous leucocytoclastic vasculitis following the re-introduction of azathioprine. " 11/01/1993 - "azathioprine 1-2 mg/kg) seems to decrease the risk of recurrent systemic vasculitis." Order ALL the reference details at left...

Related Drugs and Biologics

1.	6-Mercaptopurine (Mercaptopurine)
2.	Cyclophosphamide (Cytoxan)
3.	Prednisone (Sone)
4.	Adrenal Cortex Hormones (Corticosteroids)
5.	Cyclosporine (Ciclosporin)
6.	Methotrexate (Mexate)
7.	Prednisolone (Predate)
8.	Steroids
9.	Methylprednisolone
10.	infliximab (Remicade)

Related Therapies and Procedures

1.	Plasmapheresis
2.	Plasma Exchange
3.	Kidney Transplantation
4.	Transplants (Transplant)
5.	Remission Induction

Best Treatments:
Research Summary Report
on Crohn Disease

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 1095 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>